Sreekanth K. Chaguturu - Apr 1, 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Chief Medical Officer
Signature
/s/ Sreekanth K. Chaguturu
Stock symbol
CVS
Transactions as of
Apr 1, 2024
Transactions value $
$2,653,326
Form type
4
Date filed
4/3/2024, 05:03 PM
Previous filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Tax liability -$117K -1.47K -10.9% $79.56 12K Apr 1, 2024 Direct F1
transaction CVS Common Stock Tax liability -$65.6K -825 -6.85% $79.56 11.2K Apr 1, 2024 Direct F2
transaction CVS Common Stock (Restricted) Award $550K +6.91K +41.26% $79.56 23.7K Apr 1, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $2.29M +28.7K $79.56 28.7K Apr 1, 2024 Common Stock 28.7K $79.56 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
F2 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units.
F3 Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments, commencing 4/1/2025.
F4 Option becomes exercisable in four equal annual installments, commencing 4/1/2025.